516: Illuminating the Science for All to See | Usama Malik, CFO, Immunomedics
“It’s the economics, the finance,” says CFO Usama Malik, who quickly adds the words “and the accounting” to his short list of finance leader action items. Malik begins where most CFOs end–with the economics behind the business model. Everything else follows, he explains.
“This role is about applying a broader lens to an entire industry and figuring out a competitive advantage,” adds Malik, who, while bullish on the science behind Immunomedics’ future offerings, makes clear his contention that it’s the economics that will ultimately determine the company’s fate.
“Historically, there have been…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.